1. Introduction {#sec1}
===============

*Mythimna separata* Walker (oriental armyworm), also known as the Northern armyworm, is a typical crop-threatening pest, which is mainly distributed in China, India, Korea, and also other countries.^[@ref1],[@ref2]^ The larvae of this insect pest can cause a great deal of damage to many cereal crops such as wheat, maize, and rice during its seasonal outbreaks.^[@ref3],[@ref4]^ Although lots of synthetic chemical pesticides have been used to control insect pest outbreaks and also have played a crucial role in modern agriculture, the overuse and abuse of synthetic chemical pesticides over the years lead to considerable concern for pest resistance, pesticide residue, and other side effects on human health.^[@ref5]−[@ref7]^ Thus, there are urgent needs to discover new promising alternatives from the sustainable natural bioresources to effectively and selectively control the insect pest.

Sarisan (**I**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), possessing a piperonyl moiety, is a biorenewable manoligan and isolated from many species of plants, such as *Ligusticum mutellina*,^[@ref8]^*Piper solmsianum* C. DC,^[@ref9]^*Piper sarmentosum*,^[@ref10]^*Saururus chinensis*,^[@ref11]^ and *Beilschmiedia miersii*.^[@ref12]^ Its isomer, myristicin (**II**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), is a well-known synergist for carbamates, pyrethroids, and other pesticides, of which synergistic activity is similar to commercial synergist piperonyl butoxide^[@ref12],[@ref13]^ (**V**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Sarisan also shows a variety of biological activities including antimicrobial activity,^[@ref8]^ anti-septic activity,^[@ref12]^ and psychopharmacologic effect,^[@ref14]^ especially its pesticidal activity against armyworms^[@ref15]^ and different kinds of mosquitoes.^[@ref16]^ In addition, pyrazole derivatives are one of the most interesting class of *N*-heterocyclic compounds that have remarkable biological activities in the areas of both pharmacological and agricultural activities, such as anticancer,^[@ref17],[@ref18]^ antitubercular,^[@ref19]^ antimicrobial,^[@ref20]^ analgesic,^[@ref21]^ insecticidal,^[@ref22]^ acaricidal,^[@ref23]^ herbicidal activities,^[@ref24]^ and so forth. The well-known fipronil (**III**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) is a representative pesticide containing the *N*-phenylpyrazole moiety for control of insects on wheat, corn, and other cereal crops, which was exploited by Rhône-Poulenc Inc., in 1987 and showed prominent insecticidal activity.^[@ref25]^ In 1996, Bayer CropScience AG discovered another well-known insecticide ethiprole (**IV**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), which belongs to fipronil derivative.^[@ref26]^ The difference between them is that only trifluoromethylsulfinyl of fipronil was substituted by ethylsulfinyl. What is more, as far as we know, little attention has been paid to the introduction of the active substructure *N*-phenylpyrazole at the active position (C-3, 6, 1′, 2′, or 3′ position) of sarisan. Inspired by these interesting results and also in prolongation of our research on the discovery of new biorenewable natural product-based pesticides, in this paper, we designed and took advantage of iodine as a mediator to smoothly synthesize a series of *N*-phenylpyrazole sarisan analogues by one-pot methodology. Besides, we have evaluated the insecticidal activity of all the title compounds against *M. separata* and discussed the structure--activity relationships (SARs).

![Structures of sarisan (**I**) and its related compounds (**II--V**).](ao-2017-01106u_0001){#fig1}

2. Results and Discussion {#sec2}
=========================

2.1. Synthesis {#sec2-1}
--------------

As shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, compounds **2--4** and the key intermediate 3-formylsarisan (**5**) were acquired as per our reported procedures.^[@ref27]^ We used sesamol as the starting material to synthesize sarisan analogues instead of utilizing sarisan separated from plants, which not only can save economic costs but also can protect plant resources. First, sesamol was reacted with allylbromide and K~2~CO~3~ to afford allyl ether **2** in 93% yield, followed by Claisen rearrangement to afford phenol **3**. Second, compound **3** was reacted with SnCl~4~, paraformaldehyde, and 1,8-diazabicyclo\[5.4.0\]undec-7-ene to afford **4** in 58% yield, and then methylation of compound **4** with CH~3~I--K~2~CO~3~ in acetone smoothly afforded 3-formylsarisan (**5**) in 87% yield. Finally, compound **6** was prepared by the condensation of compound **5** with acetophenone in KOH/MeOH/H~2~O and subsequently reacted with the corresponding hydrazine hydrochlorides **7a--t** in EtOH to afford the target *N*-phenylpyrazole sarisan analogues **8a--t** via I~2~-mediated oxidative cyclization. The structures of all target compounds were characterized through ^1^H/^13^C NMR, infrared (IR) spectroscopy, and melting point (mp).

![Synthetic Route for the Preparation of *N*-Phenylpyrazole Sarisan Analogues **8a--t**](ao-2017-01106u_0006){#sch1}

However, above all, considering the synthesis of compound **8a** as the template ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), the reaction conditions for the synthesis of *N*-phenylpyrazole sarisan analogues via I~2~-mediated oxidative cyclization and different solvents were investigated. Initially, we investigated the amount of iodine for the one-pot synthesis of **8a** in EtOH at reflux. The results indicated that a mixture of **6** and **7a** in the presence of molecular iodine (2.0 equiv) was the best reaction condition and gave **8a** in 89% yield. To further optimize the reaction conditions, we screened two commonly used solvents \[*N*,*N*-dimethylformamide (DMF) and dimethyl sulfoxide (DMSO)\] and found that this reaction did not proceed well in DMF/DMSO at 80 °C in the presence of 2.0 equiv of I~2~. Especially, when DMSO was used as the solvent, only a very small amount of **8a** was formed in 7% yield. With the optimal one-pot reaction conditions (1.0 equiv of **6**, 2.0 equiv of **7a**, and 2.0 equiv of iodine in ethanol at refluxing temperature) in hand, we continued to optimize the reaction conditions by using two-step condensation. At first, compound **6** was condensed with **7a** in ethanol at reflux to form the intermediate hydrazone **6a**. After the first-step condensation was complete, compound **6a** was separated from the reaction system, redissolved in EtOH, treated with 2.0 equiv of I~2~, and then heated to reflux, which also provided the desired compound **8a** in 75% yield. In addition, a plausible mechanism for the formation of these *N*-phenylpyrazole sarisan analogues **8a--t** is proposed. As shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, the oxidative iodination of hydrazone **6a--t** produces iodide intermediates **A--T**. Subsequently, intermediates **A′--T′** are formed via an S~N~2′-type cyclization of compounds **A--T**, with the formation of a new C--N bond. Finally, the deprotonation of compounds **A′--T′** affords the target *N*-phenylpyrazole sarisan analogues **8a--t**.

![Proposed Mechanism for the Formation of *N*-Phenylpyrazole Sarisan Analogues **8a--t**](ao-2017-01106u_0007){#sch2}

###### Optimization of the Reaction Conditions for the Synthesis of Compound **8a**[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-01106u_0008){#GRAPHIC-d119e598-autogenerated}

  entry                               substrates       equiv of I~2~   solvent   temp     yield (%)[b](#t1fn2){ref-type="table-fn"}
  ----------------------------------- ---------------- --------------- --------- -------- -------------------------------------------
  1[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   1.0             EtOH      reflux   69
  2[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   1.5             EtOH      reflux   73
  3[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   2.0             EtOH      reflux   89
  4[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   2.5             EtOH      reflux   70
  5[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   2.0             DMF       80 °C    60
  6[c](#t1fn3){ref-type="table-fn"}   **6** + **7a**   2.0             DMSO      80 °C    7
  7[d](#t1fn4){ref-type="table-fn"}   **7a**           2.0             EtOH      reflux   75

Optimal reaction conditions (entry 3): **6** (0.4 mmol), **7a** (0.8 mmol), I~2~ (0.8 mmol), EtOH, and reflux.

Isolated yields after silica gel column chromatography.

A reaction mixture of **6**, **7a**, and I~2~ in EtOH/DMF was directly heated to reflux.

First, a mixture of **6** and **7a** in EtOH was stirred at reflux, and after the reaction was complete, **6a** was separated from the reaction system and then redissolved in EtOH, treated with I~2~, and heated to reflux.

2.2. Insecticidal Activity {#sec2-2}
--------------------------

As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, the insecticidal activity of compounds **I** and **8a--t** against *M. separata* Walker was evaluated as the final mortality rates (FMRs) at 1 mg mL^--1^. Toosendanin, a commercial insecticide derived from *Melia azedarach*, was used as the positive control. We used corn leaves treated with acetone alone as a blank control. Among all the tested samples, compounds **8c** and **8e** showed equivalent insecticidal activity to the positive control toosendanin with the FMR = 51.7%, which was higher than the parent compound **I** with the FMR = 44.8%. Compounds **8b** and **8l--r** exhibited more potent insecticidal activity than toosendanin, and their FMRs were all higher than 51.7%. Especially, compound **8r** showed excellent insecticidal activity with the FMR = 79.3%, which was 27.6% higher than that of toosendanin. In addition, we found that the corresponding FMRs of 33 days were generally higher than those of 20 and 10 days, which indicated that these title compounds showed delayed insecticidal activity.^[@ref28]^ Administration of the target compounds to the larvae of *M. separata* resulted in an array of developmental abnormalities, affecting growth, molting, and metamorphosis. For example, as shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, because of feeding too much of compound-treated leaves within the first 48 h, some larvae died with the symptoms of blackened, wrinkled, and dehydrated bodies. This phenomenon may be due to the effects of the *N*-phenylpyrazole sarisan analogues on nutritional or digestive interference.^[@ref29],[@ref30]^ In the second stage of pupation, many pupae could not molt into normal pupae and then died ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Similarly, during the last stage of the emergence period, many malformed moths were observed with shrunk, short, or immature wings and dead toward the end ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). The appearance of these malformed pupae and moths suggested that these compounds might disrupt the endocrine control of molting.^[@ref31],[@ref32]^ This experimental phenomenon was different from traditionally synthetic pesticides, such as organophosphates, organochlorine pesticides, and so forth, which often kill most of the insect pests within a few hours^[@ref33]^ This symptom indicated that the effect of the title compounds could cause toxicity to the treated larvae as they suffered from ecdysial stasis and inhibition of development, resulting in the suppression of larval--pupal ecdysis and adult emergence. In this way, these *N*-phenylpyrazole sarisan analogues can affect reproduction, reducing egg production and disrupting endocrine system.^[@ref34],[@ref35]^ On the other hand, to make further investigation of this phenomenon, we analyzed the percentages of FMRs of the representative compounds **8l--r** and toosendanin at three different growth stages of *M. separata* ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). We found that more than half of dead *M. separata* due to compounds **8l--r** and toosendanin were at the larval period. This result could further demonstrate that the administration of the target compounds to the treated insect pests mainly inhibit larval--pupal ecdysis, which resulted in the death of most of the insects during pupation.

![The representative abnormal larvae pictures of **8c** (QLL-89), **8d** (QLL-91), **8j** (QLL-95), **8l** (QLL-100), **8n** (QLL-94), **8q** (QLL-98), and **8r** (QLL-103) during the larval period (CK: blank control group).](ao-2017-01106u_0002){#fig2}

![The representative malformed pupae pictures of **8b** (QLL-90), **8d** (QLL-91), **8e** (QLL-88), **8j** (QLL-95), **8l** (QLL-100), **8n** (QLL-94), and **8p** (QLL-97) during the pupation period (CK: blank control group).](ao-2017-01106u_0003){#fig3}

![The representative malformed moth pictures of **8b** (QLL-90), **8c** (QLL-89), **8j** (QLL-95), **8n** (QLL-94), **8p** (QLL-97), **8q** (QLL-98), and **8r** (QLL-103) during the emergence period (CK: blank control group).](ao-2017-01106u_0004){#fig4}

![The percentages of the FMRs of compounds **8l**, **8m**, **8n**, **8o**, **8p**, **8q**, and **8r** and toosendanin during three different growth periods.](ao-2017-01106u_0005){#fig5}

###### Insecticidal Activity of Compounds **I** and **8a--t** against *M. separata* on Leaves Treated at a Concentration of 1 mg mL^--1^[a](#t2fn1){ref-type="table-fn"}

                     corrected mortality rate (±SD)                 
  ------------------ -------------------------------- ------------- -------------
  sarisan (**I**)    13.3 (±3.3)                      26.7 (±3.3)   44.8 (±3.3)
  **8a** (QLL-105)   13.3 (±3.3)                      33.3 (±3.3)   44.8 (±6.7)
  **8b** (QLL-90)    30.0 (±5.8)                      46.7 (±6.7)   55.2 (±3.3)
  **8c** (QLL-89)    26.7 (±3.3)                      46.7 (±3.3)   51.7 (±3.3)
  **8d** (QLL-91)    16.7 (±3.3)                      33.3 (±3.3)   44.8 (±3.3)
  **8e** (QLL-88)    23.3 (±3.3)                      40.0 (±5.8)   51.7 (±3.3)
  **8f** (QLL-87)    16.7 (±3.3)                      33.3 (±3.3)   44.8 (±3.3)
  **8g** (QLL-81)    20.0 (±0)                        33.3 (±3.3)   44.8 (±3.3)
  **8h** (QLL-99)    16.7 (±3.3)                      26.7 (±3.3)   34.5 (±3.3)
  **8i** (QLL-93)    20.0 (±0)                        33.3 (±3.3)   41.4 (±3.3)
  **8j** (QLL-95)    23.3 (±3.3)                      36.7 (±3.3)   44.8 (±3.3)
  **8k** (QLL-96)    16.7 (±3.3)                      30.0 (±0)     37.9 (±0)
  **8l** (QLL-100)   30.0 (±0)                        46.7 (±3.3)   65.5 (±3.3)
  **8m** (QLL-101)   23.3 (±3.3)                      43.3 (±3.3)   62.1 (±3.3)
  **8n** (QLL-94)    26.7 (±3.3)                      50.0 (±0)     69.0 (±5.8)
  **8o** (QLL-102)   30.0 (±5.8)                      46.7 (±3.3)   62.1 (±3.3)
  **8p** (QLL-97)    36.7 (±3.3)                      53.3 (±3.3)   65.5 (±3.3)
  **8q** (QLL-98)    36.7 (±3.3)                      46.7 (±3.3)   62.1 (±3.3)
  **8r** (QLL-103)   46.7 (±3.3)                      63.3 (±3.3)   79.3 (±0)
  **8s** (QLL-104)   20.0 (±0)                        33.3 (±3.3)   41.4 (±3.3)
  **8t** (QLL-106)   23.3 (±3.3)                      43.3 (±3.3)   48.3 (±5.8)
  toosendanin        13.3 (±3.3)                      40.0 (±0)     51.7 (±3.3)
  blank control      0 (±0)                           0 (±0)        3.3 (±3.3)

Values are the mean ± SD of three replicates.

Finally, we also have discovered some interesting results of SARs of the tested compounds. The introduction of *N*-(fluorophenyl)pyrazole at the C-3 position of sarisan could lead to more potent compounds than those possessing chlorophenyl, bromophenyl, and electron-donating groups on the phenyl ring \[e.g., FMRs: **8b** (55.2%), **8e** (51.7%) versus **8d** (44.8%), **8f** (44.8%), **8g** (44.8%), **8h** (34.5%), and **8k** (37.9%)\]. Interestingly, we found that the introduction of polyhalogenated phenylpyrazole at the C-3 position of sarisan could lead to more promising analogues than monohalogenated phenylpyrazole, except for compound **8t**. For example, the FMRs of **8l** (R = 3,4-difluorophenyl), **8m** (R = 3,4-dichlorophenyl), **8n** (R = 2,4-dichlorophenyl), **8o** (R = 3,5-difluorophenyl), **8p** (R = 2-chloro-4-fluorophenyl), **8q** (R = 2-chloro-5-fluorophenyl), and **8r** (R = 2-fluoro-4-bromophenyl) were all higher than 62.1%. Especially, the introduction of *N*-(2-fluoro-4-bromophenyl)pyrazole at the C-3 position of sarisan exhibited the most potent insecticidal activity.

3. Conclusions {#sec3}
==============

In summary, a series of novel *N*-phenylpyrazole sarisan analogues were prepared and their insecticidal activities were evaluated against a crop-threatening agricultural insect pest, *M. separata* Walker. Among all the target compounds, compounds **8l--r** exhibited more promising insecticidal activity with their FMRs higher than 62.1%, when compared with the positive control toosendanin. Especially, compound **8r** with 2-fluoro-4-bromophenyl showed the most potent insecticidal activity, whose FMR was 79.3%. On the other hand, we have established an efficient methodology for the synthesis of *N*-phenylpyrazole sarisan analogues through iodine-mediated oxidative intramolecular C--N bond formation. This practical one-pot methodology is metal-free and requires no separation of the less stable intermediates hydrazones. Their SARs indicated that introduction of *N*-(fluorophenyl)pyrazole or polyhalogenated phenylpyrazole at the C-3 position of sarisan could lead to more potent compounds, especially introduction of *N*-(2-fluoro-4-bromo-phenyl)pyrazole. These promising results are of importance to the application of sarisan analogues as biorenewable pesticidal agents in crop protection.

4. Experimental Section {#sec4}
=======================

4.1. Instrument and Materials {#sec4-1}
-----------------------------

Sesamol (99.0%) and different substituted phenylhydrazine hydrochlorides (95.0%) were obtained from Macklin Biochemical Inc. Analytical thin-layer chromatography (TLC) and preparative TLC (PTLC) were performed by silica gel plates using silica gel GF~254~ (Qingdao Haiyang Chemical Co., Ltd., Qingdao, China). Other reagents were of analytical grade and purchased from Innochem Co., Ltd. and KeLong Chemical Reagent Co., Ltd. Anhydrous solvents were purified and dried in terms of standard procedures. The mps were recorded on a digital mp instrument (Beijing Tech Instrument Co., Ltd.) and were uncorrected. IR spectra were detected as dry films (KBr) on a PE-1710 Fourier-transform-IR spectrometer (PerkinElmer, Waltham, MA, USA). The ^1^H/^13^C NMR data were recorded on a Bruker Avance (400/100 MHz) NMR spectrometer (Bruker, Bremerhaven, Germany) using CDCl~3~ as the solvent and tetramethylsilane as the internal standard. In addition, compounds **2--5** were prepared using the same method as our previous report.^[@ref27]^

4.2. General Procedure for the Synthesis of Compound **6** {#sec4-2}
----------------------------------------------------------

A mixture of compound **5** (5 mmol, 1100.4 mg), acetophenone (7.5 mmol, 901.1 mg), and KOH (15 mmol, 841.5 mg) in MeOH/H~2~O (2:1 v/v) was stirred at 0--5 °C for 2 h. When the reaction was complete, the mixture was diluted with water (10 mL) and extracted with CH~2~Cl~2~ (20 mL × 3). The combined organic layer was dried over anhydrous sodium sulfate, concentrated, and purified through silica gel column chromatography (petroleum ether/ethyl acetate, 8:1, v/v) to afford the desired ketone α,β-unsaturated **6**.

### 4.2.1. Data for **6** {#sec4-2-1}

Yellow solid: yield 99%; ^1^H NMR (400 MHz, CDCl~3~): δ 8.04 (d, *J* = 7.2 Hz, 2H, −Ph), 7.88--7.98 (m, 2H, double bond), 7.56--7.60 (m, 1H, −Ph), 7.48 (t, *J* = 7.2 Hz, 2H, −Ph), 6.71 (s, 1H, H-6), 6.09 (s, 2H, −OCH~2~O−), 5.88--5.98 (m, 1H, H-2′), 5.06--5.10 (m, 2H, H-3′), 3.73 (s, 3H, −OCH~3~), 3.35 (d, *J* = 6.4 Hz, 2H, H-1′).

4.3. General Procedure for the Synthesis of Compound **6a** {#sec4-3}
-----------------------------------------------------------

A mixture of compound **6** (0.4 mmol, 128.8 mg) and phenylhydrazine hydrochloride (0.8 mmol, 115.7 mg) in absolute ethanol (10 mL) was refluxed. After the reaction was complete depending on TLC analysis, the solvent was concentrated under reduced pressure. The residue was finally purified by PTLC to provide the intermediate **6a**.

### 4.3.1. Data for **6a** {#sec4-3-1}

White solid: yield 98%; ^1^H NMR (400 MHz, DMSO): δ 8.86 (s, 1H, −NH−), 7.53--7.63 (m, 3H, −Ph), 7.44 (d, *J* = 16.4 Hz, 1H, double bond), 7.31 (d, *J* = 6.8 Hz, 2H, −Ph), 7.17 (d, *J* = 4.0 Hz, 4H, −Ph), 6.74--6.78 (m, 1H, −Ph), 6.61 (s, 1H, H-6), 6.11 (d, *J* = 16.4 Hz, 1H, double bond), 6.10 (s, 2H, −OCH~2~O−), 5.82--5.92 (m, 1H, H-2′), 4.98--5.02 (m, 2H, H-3′), 3.38 (s, 3H, −OCH~3~), 3.20 (d, *J* = 6.4 Hz, 2H, H-1′). ^13^C NMR (100 MHz, DMSO): δ 149.2, 146.0, 144.7, 143.3, 143.3, 137.3, 134.3, 131.8, 129.3, 129.0, 128.5, 128.7, 124.8, 121.1, 119.4, 115.6, 113.9, 113.1, 107.8, 101.4, 61.3, 33.1.

4.4. General Procedure for the Synthesis of Compounds **8a--t** {#sec4-4}
---------------------------------------------------------------

To a stirred solution of α,β-unsaturated ketone **6** (0.4 mmol, 128.8) and the corresponding hydrazine hydrochlorides (0.8 mmol, 115.7 mg) in ethanol was added molecular iodine (0.8 mmol, 203.0 mg), and then the reaction was heated to reflux under N~2~. When the reaction was complete according to TLC analysis, the solvent was concentrated, quenched with 5% Na~2~S~2~O~3~, and then extracted with ethyl acetate (20 mL × 3). The combined organic layer was dried over anhydrous sodium sulfate, concentrated, and purified through PTLC to afford the target compounds **8a--t**. The example data of compounds **8a--e** are listed as follows, whereas those of other compounds are depicted in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01106/suppl_file/ao7b01106_si_001.pdf).

### 4.4.1. Data for **8a** {#sec4-4-1}

Yellow liquid: yield 89%; IR cm^--1^ (KBr): 3065, 2932, 2896, 1599, 1499, 1457, 1399, 1207, 1051, 768, 693; ^1^H NMR (400 MHz, CDCl~3~): δ 7.93 (d, *J* = 7.2 Hz, 2H, −Ph), 7.40--7.44 (m, 4H, −Ph), 7.30--7.35 (m, 3H, −Ph), 7.23--7.27 (m, 1H, −Ph), 6.94 (s, 1H, H-6), 6.66 (s, 1H, H-4″), 5.82--5.92 (m, 1H, H-2′), 5.71 (s, 2H, −OCH~2~O−), 4.96--5.05 (m, 2H, H-3′), 3.44 (s, 3H, −OCH~3~), 3.27 (d, *J* = 6.4 Hz, 2H, H-1′); ^13^C NMR (100 MHz, CDCl~3~): δ 152.0, 149.9, 144.5, 143.4, 140.8, 137.0, 134.9, 133.0, 128.6, 128.6, 127.9, 127.0, 125.8, 123.4, 115.7, 110.0, 107.8, 106.8, 101.4, 61.2, 33.9.

### 4.4.2. Data for **8b** {#sec4-4-2}

Yellow liquid: yield 61%; IR cm^--1^ (KBr): 3704, 2933, 2887, 1508, 1459, 1208, 1050, 764, 668; ^1^H NMR (400 MHz, CDCl~3~): δ 7.92 (d, *J* = 7.6 Hz, 2H, −Ph), 7.40--7.50 (m, 4H, −Ph), 7.29--7.35 (m, 1H, −Ph), 7.05--7.17 (m, 2H, −Ph), 7.00 (s, 1H, H-6), 6.62 (s, 1H, H-4″), 5.79--5.87 (m, 1H, H-2′), 5.67 (s, 2H, −OCH~2~O−), 4.90--5.01 (m, 2H, H-3′), 3.46 (s, 3H, −OCH~3~), 3.24 (d, *J* = 6.0 Hz, 2H, H-1′).

### 4.4.3. Data for **8c** {#sec4-4-3}

Yellow liquid: yield 88%; IR cm^--1^ (KBr): 3063, 2931, 2899, 1492, 1456, 1207, 1121, 1048, 764, 694; ^1^H NMR (400 MHz, CDCl~3~): δ 7.92 (d, *J* = 7.6 Hz, 2H, −Ph), 7.38--7.43 (m, 4H, −Ph), 7.31--7.34 (m, 1H, −Ph), 7.20--7.28 (m, 2H, −Ph), 6.97 (s, 1H, H-6), 6.60 (s, 1H, H-4″), 5.73--5.83 (m, 3H, −OCH~2~O--, and H-2′), 4.94 (dd, *J* = 1.6, 10.0 Hz, 1H, H-3′), 4.82 (dd, *J* = 1.6, 17.6 Hz, 1H, H-3′), 3.47 (s, 3H, −OCH~3~), 3.19 (d, *J* = 6.4 Hz, 2H, H-1′).

### 4.4.4. Data for **8d** {#sec4-4-4}

Yellow liquid: yield 82%; IR cm^--1^ (KBr): 3071, 2933, 2890, 1594, 1484, 1456, 1207, 1052, 766, 660; ^1^H NMR (400 MHz, CDCl~3~): δ 7.92 (d, *J* = 7.2 Hz, 2H, −Ph), 7.56 (s, 1H, −Ph), 7.41--7.45 (m, 2H, −Ph), 7.32--7.36 (m, 1H, −Ph), 7.20--7.26 (m, 3H, −Ph), 6.94 (s, 1H, H-6), 6.69 (s, 1H, H-4″), 5.83--5.93 (m, 1H, H-2′), 5.79 (s, 2H, −OCH~2~O−), 4.96--5.06 (m, 2H, H-3′), 3.42 (s, 3H, −OCH~3~), 3.27 (d, *J* = 6.4 Hz, 2H, H-1′).

### 4.4.5. Data for **8e** {#sec4-4-5}

White solid: yield 67%; mp 63--65 °C; IR cm^--1^ (KBr): 3074, 2974, 2938, 2892, 1511, 1467, 1210, 1053, 851, 769, 693; ^1^H NMR (400 MHz, CDCl~3~): δ 7.91 (d, *J* = 7.2 Hz, 2H, −Ph), 7.37--7.44 (m, 4H, −Ph), 7.31--7.35 (m, 1H, −Ph), 6.98 (t, *J* = 8.4 Hz, 2H, −Ph), 6.93 (s, 1H, H-6), 6.67 (s, 1H, H-4″), 5.82--5.92 (m, 1H, H-2′), 5.76 (s, 2H, −OCH~2~O−), 4.95--5.05 (m, 2H, H-3′), 3.43 (s, 3H, −OCH~3~), 3.26 (d, *J* = 6.4 Hz, 2H, H-1′).

4.5. Biological Assay {#sec4-5}
---------------------

The insecticidal activity of compounds **I** and **8a--t** against *M. separata* was evaluated by the leaf-dipping method in line with the previously reported method.^[@ref36],[@ref37]^ Thirty pre-third-instar larvae of the same size and level of health (10 larvae per group) were chosen as the tested pests for each compound. Acetone solutions of compounds **I** and **8a--t** and toosendanin (used as a positive control) were prepared at the concentration of 1 mg mL^--1^. Fresh corn leaves were cut into leaf disks (1 × 1 cm^2^), dipped into the sample solution for 3 s, then taken out, and dried in RT. The larvae of tested groups were fed with compound-coated leaves, whereas the larvae of blank control group (CK) were fed with acetone-treated leaves alone. Several treated leaf disks were kept in each dish. Once the treated leaves were consumed, the corresponding ones were added to the dish. After 48 h, the larvae were treated with untreated fresh leaves and observed until the adult emergence (temperature: 25 ± 2 °C; relative humidity: 65--80%; and photoperiod: (light/dark) = 12/12 h). The corrected mortality rate values of the tested compounds were calculated by the following formula: corrected mortality rate (%) = (*T* -- *C*) × 100/(1 -- *C*), where *T* is the mortality rate of the tested samples and *C* is the mortality rate of CK.
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